Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2025 -341.6%
December 31, 2024 -164.1%
September 30, 2024 -217.2%
June 30, 2024 -419.8%
March 31, 2024 -166.3%
December 31, 2023 -180.7%
September 30, 2023 -172.8%
June 30, 2023 -228.2%
March 31, 2023 -330.2%
December 31, 2022 -362.8%
September 30, 2022 -449.0%
June 30, 2022 -385.8%
March 31, 2022 -278.5%
December 31, 2021 -194.1%
September 30, 2021 -42.40%
June 30, 2021 -14.03%
March 31, 2021 -19.12%
December 31, 2020 -11.04%
September 30, 2020 -23.62%
June 30, 2020 -36.07%
March 31, 2020 -61.56%
December 31, 2019 -73.85%
September 30, 2019 -96.81%
June 30, 2019 -71.48%
March 31, 2019 -42.89%
Date Value
December 31, 2018 -25.62%
September 30, 2018 -99.63%
June 30, 2018 -128.3%
March 31, 2018 -220.7%
December 31, 2017 -88.34%
September 30, 2017 -257.7%
June 30, 2017
March 31, 2017 -1.19K%
December 31, 2016 -39.89%
September 30, 2016 -554.9%
June 30, 2016 -385.9%
March 31, 2016 -589.6%
December 31, 2015 87.48%
September 30, 2015 -1.39K%
June 30, 2015 -124.4%
March 31, 2015 -60.05%
December 31, 2014 -159.1%
September 30, 2014 -56.76%
June 30, 2014 -8.80K%
March 31, 2014
December 31, 2013 -320.1%
September 30, 2013
June 30, 2013 -4.87K%
March 31, 2013
December 31, 2012 -3.21K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
HealthEquity, Inc. 18.71%
Hims & Hers Health, Inc. -11.46%
Frélii, Inc. --
Genesis Healthcare, Inc. --
Pharmagen, Inc. --